The results are in for our annual look at the state of the chain technology market. We’ll highlight key findings from our 2016 survey in a roundtable discussion among three chain pharmacy executives.
We hear a lot these days about big data and how this is transforming the high-tech industry. Healthcare is one of the markets targeted by cloud platforms and big data, and the trends are gaining traction.
DIR are nothing more than a rip-off of pharmacies by the PBMs, a number of HIEs are on shaky ground financially, and just the latest on CMS HITECH onboarding of noneligible providers such as pharmacies for Medicaid programs.
Pharmacies are now competing on so many fronts — to be in payer networks, to offer additional services, to achieve high-quality metrics to retain patients — it is a challenge to evaluate all of the options and determine the best approach to be successful.
Fifty years ago (1966) Medicaid started to exist. I was the staff person in charge of all the Medi-Cal drug program’s policies.There are many fascinating stories to tell.
Bill just returned from a health benefit managers’ business coalition meeting where national leaders were telling attendees that employers need to control healthcare costs going forward.
The Centers for Medicare & Medicaid Services (CMS) published the Medicaid Program Covered Outpatient Drugs final rule in the Federal Register on February 1. This publication ended a 10-year regulatory odyssey that began in 2006.
Jason Briscoe from Discount Drug Mart, Inc., and Karen Merrill from GRX Holdings offer their thoughts on health information exchange, how to deliver patient education more effectively, rules-based patient-management protocols, and more.
In a conversation with Trey Tollstam from Synergy Medical, we hear how the incentives with star ratings are moving pharmacies toward different strategies. Maybe...